Details for New Drug Application (NDA): 061016
✉ Email this page to a colleague
NDA 061016 describes TERRA-CORTRIL, which is a drug marketed by Pfizer and is included in one NDA. Additional details are available on the TERRA-CORTRIL profile page.
The generic ingredient in TERRA-CORTRIL is hydrocortisone acetate; oxytetracycline hydrochloride. There are sixty-seven drug master file entries for this compound. Additional details are available on the hydrocortisone acetate; oxytetracycline hydrochloride profile page.
The generic ingredient in TERRA-CORTRIL is hydrocortisone acetate; oxytetracycline hydrochloride. There are sixty-seven drug master file entries for this compound. Additional details are available on the hydrocortisone acetate; oxytetracycline hydrochloride profile page.
Summary for 061016
| Tradename: | TERRA-CORTRIL |
| Applicant: | Pfizer |
| Ingredient: | hydrocortisone acetate; oxytetracycline hydrochloride |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SUSPENSION;OPHTHALMIC | Strength | 1.5%;EQ 5MG BASE/ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
